Responders and non-responders to romosozumab treatment
Journal of Bone and Mineral Metabolism · 2025-01 · 43 (1) · 18-21
DOI: 10.1007/s00774-024-01570-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 07.12.2024. Verfasst von Ayako Tominaga und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Tokyo Women's Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Osteoporosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Tokyo Women’s Medical University Career Development Center for Medical Professionals.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Orthopedic Surgery, Tokyo Women's Medical University, Tokyo, Japan. keijiwadajp@yahoo.co.jp.
- Kita Shinagawa 3rd Hospital, Tokyo, Japan.
Förderung
- Tokyo Women’s Medical University Career Development Center for Medical Professionals
Zitieren
APA
Tominaga, A., Wada, K., Kato, Y., & Okazaki, K. (2025). Responders and non-responders to romosozumab treatment. Journal of Bone and Mineral Metabolism, 43(1), 18-21. https://doi.org/10.1007/s00774-024-01570-y
Vancouver
Tominaga A, Wada K, Kato Y, Okazaki K. Responders and non-responders to romosozumab treatment. Journal of Bone and Mineral Metabolism. 2025;43(1):18-21. doi:10.1007/s00774-024-01570-y
BibTeX
@article{Tominaga2025,
author = {Tominaga, Ayako and Wada, Keiji and Kato, Yoshiharu and Okazaki, Ken},
title = {Responders and non-responders to romosozumab treatment},
journal = {Journal of Bone and Mineral Metabolism},
year = {2025},
volume = {43},
number = {1},
pages = {18--21},
doi = {10.1007/s00774-024-01570-y}
}
EUVIMED